Unlock a broad range of applications with one powerful instrument
All Kits & Reagents
Improved Q30 score, support for UMIs, extended shelf life, and support for Illumina DNA PCR-Free Library Prep
All Selection & Planning Tools
Discover novel trait and disease associations with optimized tag SNPs and functional exonic content at an attractive price
All Software & Informatics Products
DRAGEN v3.10 release now available, setting new standards for accuracy and increased genome coverage.
Fast, high-quality, sample-to-data next-generation sequencing services
All Popular Products
All Informatics Education
More About Us
Empower the next generation of scientists and engineers through educational opportunities and resources
More Career Info
All Investor Information
More Business Solutions
All Legal Information
All Support Tools
All Product Support Services
Solutions to enable comprehensive genomic profiling, from tissue to liquid biopsy samples
All Cancer Research Products
All Microbial Genomics Research
Monitor SARS-CoV-2 variants and other respiratory viruses in the community
All Microbial Genomics Products
All Informatics Products
A collaboratively designed universal genotyping platform can keeping costs reasonable and provide optimal outcomes
All Agrigenomics Products
See what is possible through the latest advances in high-throughput sequencing technology
All Complex Disease Research Products
All Reproductive Health
Sequencing with the VeriSeq NIPT Solution v2 enables comprehensive insights reducing the need for invasive tests
All Reproductive Health Products
Technology innovation and collaboration in health care to ensure families receive a diagnosis early
All Genetic Health Products
Using a single test assessing hundreds of current and
emerging cancer biomarkers, you can now access a
clinically relevant report with actionable answers.
The MiSeqDx instrument is the first FDA-cleared <i>in vitro</i> diagnostic (IVD) next-generation sequencing (NGS) system.
MiSeqDx applications include FDA-cleared and FDA-approved assays for cystic fibrosis testing, colorectal cancer evaluation, and NGS-based assay development.
FDA-cleared next-generation sequencing panels for detection of causative and clinically relevant variants for cystic fibrosis.